358 related articles for article (PubMed ID: 20472091)
21. Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.
Tomusiak A; Strus M; Heczko PB; Adamski P; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M
Drug Des Devel Ther; 2015; 9():5345-54. PubMed ID: 26451088
[TBL] [Abstract][Full Text] [Related]
22. Persistence of Lactobacilli in Postmenopausal Women - A Double-Blind, Randomized, Pilot Study.
Kwak YK; Daroczy K; Colque P; Kühn I; Möllby R; Kopp Kallner H
Gynecol Obstet Invest; 2017; 82(2):144-150. PubMed ID: 27376550
[TBL] [Abstract][Full Text] [Related]
23. Species diversity and relative abundance of vaginal lactic acid bacteria from women in Uganda and Korea.
Jin L; Tao L; Pavlova SI; So JS; Kiwanuka N; Namukwaya Z; Saberbein BA; Wawer M
J Appl Microbiol; 2007 Apr; 102(4):1107-15. PubMed ID: 17381754
[TBL] [Abstract][Full Text] [Related]
24. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
Rostok M; Hütt P; Rööp T; Smidt I; Štšepetova J; Salumets A; Mändar R
Benef Microbes; 2019 Apr; 10(4):385-393. PubMed ID: 30882242
[TBL] [Abstract][Full Text] [Related]
25. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment.
Santos CMA; Pires MCV; Leão TL; Hernández ZP; Rodriguez ML; Martins AKS; Miranda LS; Martins FS; Nicoli JR
Microbiology (Reading); 2016 Jul; 162(7):1195-1207. PubMed ID: 27154285
[TBL] [Abstract][Full Text] [Related]
26. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
Schwebke JR; Morgan FG; Koltun W; Nyirjesy P
Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602
[TBL] [Abstract][Full Text] [Related]
27. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA.
Gardiner GE; Heinemann C; Bruce AW; Beuerman D; Reid G
Clin Diagn Lab Immunol; 2002 Jan; 9(1):92-6. PubMed ID: 11777835
[TBL] [Abstract][Full Text] [Related]
28. Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis.
Han Y; Ren QL
Curr Opin Pharmacol; 2021 Dec; 61():83-90. PubMed ID: 34649216
[TBL] [Abstract][Full Text] [Related]
29. Probiotics for the treatment of women with bacterial vaginosis.
Falagas M; Betsi GI; Athanasiou S
Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
[TBL] [Abstract][Full Text] [Related]
30. Probiotics and vaginal microecology: fact or fancy?
Buggio L; Somigliana E; Borghi A; Vercellini P
BMC Womens Health; 2019 Jan; 19(1):25. PubMed ID: 30704451
[TBL] [Abstract][Full Text] [Related]
31. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.
Reid G; Beuerman D; Heinemann C; Bruce AW
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):37-41. PubMed ID: 11750220
[TBL] [Abstract][Full Text] [Related]
32. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
[TBL] [Abstract][Full Text] [Related]
33. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.
Murina F; Graziottin A; Vicariotto F; De Seta F
J Clin Gastroenterol; 2014; 48 Suppl 1():S102-5. PubMed ID: 25291115
[TBL] [Abstract][Full Text] [Related]
34. Effect of Oral Probiotic
Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
[TBL] [Abstract][Full Text] [Related]
35. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
[TBL] [Abstract][Full Text] [Related]
36. α-Amylase in Vaginal Fluid: Association With Conditions Favorable to Dominance of Lactobacillus.
Nasioudis D; Beghini J; Bongiovanni AM; Giraldo PC; Linhares IM; Witkin SS
Reprod Sci; 2015 Nov; 22(11):1393-8. PubMed ID: 25878210
[TBL] [Abstract][Full Text] [Related]
37. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.
Mastromarino P; Macchia S; Meggiorini L; Trinchieri V; Mosca L; Perluigi M; Midulla C
Clin Microbiol Infect; 2009 Jan; 15(1):67-74. PubMed ID: 19046169
[TBL] [Abstract][Full Text] [Related]
39. Lactobacilli reduce recurrences of vaginal candidiasis in pregnant women: a randomized, double-blind, placebo-controlled study.
Ang XY; Chung FY; Lee BK; Azhar SNA; Sany S; Roslan NS; Ahmad N; Yusof SM; Abdullah N; Nik Ab Rahman NN; Abdul Wahid N; Deris ZZ; Oon CE; Wan Adnan WF; Liong MT
J Appl Microbiol; 2022 Apr; 132(4):3168-3180. PubMed ID: 34022103
[TBL] [Abstract][Full Text] [Related]
40. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis.
Hemmerling A; Harrison W; Schroeder A; Park J; Korn A; Shiboski S; Foster-Rosales A; Cohen CR
Sex Transm Dis; 2010 Dec; 37(12):745-50. PubMed ID: 20644497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
